These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 94617)

  • 21. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.
    Ewer MS; Ali MK; Mackay B; Wallace S; Valdivieso M; Legha SS; Benjamin RS; Haynie TP
    J Clin Oncol; 1984 Feb; 2(2):112-7. PubMed ID: 6699662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
    Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy.
    Valdés Olmos RA; ten Bokkel Huinink WW; ten Hoeve RF; van Tinteren H; Bruning PF; van Vlies B; Hoefnagel CA
    Eur J Cancer; 1995; 31A(1):26-31. PubMed ID: 7695974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
    Schwartz RG; McKenzie WB; Alexander J; Sager P; D'Souza A; Manatunga A; Schwartz PE; Berger HJ; Setaro J; Surkin L
    Am J Med; 1987 Jun; 82(6):1109-18. PubMed ID: 3605130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity.
    Chia PL; Chiang K; Snyder R; Dowling A
    J Oncol Pharm Pract; 2018 Jun; 24(4):264-271. PubMed ID: 29284360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytotoxic action of doxorubicin and daunomycin on human lung cancer cells].
    Potapov IuN; Krutova TV; Korman DB; Pashkova VS
    Antibiot Med Biotekhnol; 1986 Aug; 31(8):614-7. PubMed ID: 3021047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early anthracycline cardiotoxicity.
    Bristow MR; Thompson PD; Martin RP; Mason JW; Billingham ME; Harrison DC
    Am J Med; 1978 Nov; 65(5):823-32. PubMed ID: 707541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

  • 32. Detorubicin--an active anthracycline in untreated metastatic melanoma.
    Chawla SP; Legha SS; Benjamin RS
    J Clin Oncol; 1985 Nov; 3(11):1529-34. PubMed ID: 4056844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.
    Al-Ismail S; Whittaker JA
    Br Med J; 1979 May; 1(6175):1392-5. PubMed ID: 286623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed cardiac toxicity from anthracycline therapy.
    Steinherz L; Steinherz P
    Pediatrician; 1991; 18(1):49-52. PubMed ID: 1983861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
    Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiotoxicity of anthracycline antineoplastic drugs--Clinicopathological and experimental studies.
    Suzuki T; Kanda H; Kawai Y; Tominaga K; Murata K
    Jpn Circ J; 1979 Nov; 43(11):1000-8. PubMed ID: 522231
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
    Bristow MR; Billingham ME; Mason JW; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 40. Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma.
    Tantawy AA; Elmasry OA; Shaaban M; Toaima DN; El Shahat AM
    J Pediatr Hematol Oncol; 2011 May; 33(4):e132-7. PubMed ID: 21516011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.